Issue 9/2015
Content (9 Articles)
Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide
- Editorial
Andrew J. Krentz, Ken Fujioka, Marcus Hompesch
The New Era of Drug Therapy for Obesity: The Evidence and the Expectations
- Open Access
- Leading Article
Ben J. Jones, Stephen R. Bloom
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis
- Open Access
- Leading Article
Heinz Wiendl, Sven G. Meuth
Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice
- Review Article
Julie Kalabalik, Gail B. Rattinger, Jesse Sullivan, Malgorzata Slugocki, Antonia Carbone, Anastasia Rivkin
Management Strategies for Clopidogrel Hypersensitivity
- Review Article
Craig J. Beavers, Nicolas W. Carris, Kathryn M. Ruf
Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours
- Adis Drug Evaluation
Matt Shirley, Gillian M. Keating
Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique®): A Review of Its Use as an Oral Contraceptive
- Adis Drug Evaluation
Celeste B. Burness
Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir: A Review in Chronic HCV Genotype 1 Infection
- Adis Drug Evaluation
Emma D. Deeks